The product PHER-O2 is in its pre IND phase with Cardinal Health and the University of Alberta. The company has heard from the FDA and the FDA has determined that the trial approach is as a device, which I understand from Cardinal is a very good thing.
Best regards Michael Dancy
-------------------- Let's watch it go up!
IP: Logged |